MCL1 and glioblastoma: Despite the presence of novel BH3-mimetics that selectively target Mcl-1, we decided to utilize siRNAs to assess the impact of Mcl-1 on cell-death induction in both U87, LN229, and U251 GBM cells, representing a range of different genetic backgrounds.